The panel, organized by MSQ Ventures, featured SVP & Managing Director Naveen Krishnan and discussed challenges in securing mega-round financing amid macroeconomic uncertainty and valuation pressures.
BA in Molecular Biology from William Jewell College, PhD in Molecular Biology from the University of California San Diego, and postdoctoral training at the University of California San Diego School of Medicine
Mirae Asset Capital Life Science operates across major domestic life science innovation hubs, with its investment team in Boston and San Francisco and legal and administrative support in New York.
The page states that accessing Mirae Asset Capital Life Science websites constitutes consent to the processing of personal information by Mirae Asset and its agents.
Dren Bio secures a $350 million private financing round, oversubscribed by investors. The clinical-stage biotech company focuses on developing first-in-class antibody therapeutics. This funding supports its pipeline of antibody-based treatments in development.
Mirae Asset Capital Life Science
NYC-based Mirae Asset Capital Life Science offers financial solutions for life science-focused companies.